Personalized medicine leads to better outcomes for patients with cancer
In a meta-analysis of hundreds of clinical trials involving thousands of patients, researchers report that therapeutic approaches using precision medicine, which emphasizes the use of individual genetics to refine cancer treatment, showed improved response and longer periods of disease remission, even in phase I trials.
Leave a Reply